Literature DB >> 22528460

Low-frequency ultrasound irradiation increases blood-tumor barrier permeability by transcellular pathway in a rat glioma model.

Chun-yi Xia1, Yun-hui Liu, Ping Wang, Yi-xue Xue.   

Abstract

Low-frequency ultrasound (LFU) irradiation under certain acoustic intensity can increase blood-brain barrier permeability non-invasively and reversibly. The aim of this study was to find out the effect of LFU irradiation on blood-tumor barrier (BTB) permeability in rat C6 glioma model and the possible mechanism. In this research, Evans blue and H&E staining were used to evaluate the optimal parameter of LFU to open the BTB without damaging the normal brain tissue. Transmission electron microscopy was used to observe the changes of the number of pinocytotic vesicles in cerebral or glioma microvascular endothelial cells. The phosphorylation of tyrosine kinase Src, caveolin-1, and caveolin-2 was detected by western blot. The distribution and expressing levels of caveolae proteins, caveolin-1 and caveolin-2, were detected by immunohistochemical and immunofluorescent staining, RT-PCR, and western blot. Our research data showed that, in rat C6 glioma model, LFU irradiation at a frequency of 1 MHz, a power of 12 mW, and exposure time of 20 s induced the increase of BTB permeability temporally, which reached a peak at 1.5 h, then decreased and restored to normal level at 12 h after LFU irradiation. In the glioma microvascular endothelial cells of rat glioma model, LFU irradiation induced a significant increase of the pinocytotic vesicles' density. The phosphorylation of Src, caveolin-1, and caveolin-2 began to increase at 0.5 h and reached a maximum at 1 h. Immunohistochemical and immunofluorescent staining showed that caveolin-1 and caveolin-2 were co-localized in the glioma microvascular endothelial cells and glioma cells. The mRNA and protein expression levels of caveolin-1 and caveolin-2 were up-regulated, reached the peak value at 1.5 h, and re-normalized at 12 h after LFU irradiation. These results demonstrated that LFU irradiation increased BTB permeability by promoting transcellular transport in glioma microvascular endothelial cells. The phosphorylation of tyrosine kinase Src, caveolin-1, caveolin-2 and up-regulation of caveolin-1 and caveolin-2 were involved in LFU-induced caveolae-mediated endocytosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22528460     DOI: 10.1007/s12031-012-9770-0

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  27 in total

Review 1.  Caveolae: an alternative membrane transport compartment.

Authors:  M Gumbleton; A G Abulrob; L Campbell
Journal:  Pharm Res       Date:  2000-09       Impact factor: 4.200

Review 2.  Caveolae: from basic trafficking mechanisms to targeting transcytosis for tissue-specific drug and gene delivery in vivo.

Authors:  J E Schnitzer
Journal:  Adv Drug Deliv Rev       Date:  2001-07-28       Impact factor: 15.470

Review 3.  Targeting caveolae for vesicular drug transport.

Authors:  Mark Gumbleton; Andrew J Hollins; Yadollah Omidi; Lee Campbell; Glyn Taylor
Journal:  J Control Release       Date:  2003-02-21       Impact factor: 9.776

4.  Gbetagamma activation of Src induces caveolae-mediated endocytosis in endothelial cells.

Authors:  Ayesha N Shajahan; Chinnaswamy Tiruppathi; Alan V Smrcka; Asrar B Malik; Richard D Minshall
Journal:  J Biol Chem       Date:  2004-09-02       Impact factor: 5.157

Review 5.  Blood-brain barrier delivery.

Authors:  William M Pardridge
Journal:  Drug Discov Today       Date:  2006-11-13       Impact factor: 7.851

6.  Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery.

Authors:  Kullervo Hynynen; Nathan McDannold; Natalia Vykhodtseva; Scott Raymond; Ralph Weissleder; Ferenc A Jolesz; Nickolai Sheikov
Journal:  J Neurosurg       Date:  2006-09       Impact factor: 5.115

7.  Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications.

Authors:  Kullervo Hynynen; Nathan McDannold; Nickolai A Sheikov; Ferenc A Jolesz; Natalia Vykhodtseva
Journal:  Neuroimage       Date:  2005-01-01       Impact factor: 6.556

Review 8.  Drug transfer across the blood-brain barrier and improvement of brain delivery.

Authors:  P Jolliet-Riant; J P Tillement
Journal:  Fundam Clin Pharmacol       Date:  1999       Impact factor: 2.748

9.  Src-induced phosphorylation of caveolin-2 on tyrosine 19. Phospho-caveolin-2 (Tyr(P)19) is localized near focal adhesions, remains associated with lipid rafts/caveolae, but no longer forms a high molecular mass hetero-oligomer with caveolin-1.

Authors:  Hyangkyu Lee; David S Park; Xiao Bo Wang; Philipp E Scherer; Phillip E Schwartz; Michael P Lisanti
Journal:  J Biol Chem       Date:  2002-06-28       Impact factor: 5.157

10.  Brain edema and intracerebral necrosis caused by transcranial low-frequency 20-kHz ultrasound: a safety study in rats.

Authors:  Felicitas Schneider; Tibo Gerriets; Maureen Walberer; Clemens Mueller; Roman Rolke; Bernhard M Eicke; Juergen Bohl; Oliver Kempski; Manfred Kaps; Georg Bachmann; Marianne Dieterich; Max Nedelmann
Journal:  Stroke       Date:  2006-03-23       Impact factor: 7.914

View more
  10 in total

Review 1.  Noninvasive and targeted drug delivery to the brain using focused ultrasound.

Authors:  Alison Burgess; Kullervo Hynynen
Journal:  ACS Chem Neurosci       Date:  2013-02-04       Impact factor: 4.418

2.  Low-dose endothelial monocyte-activating polypeptide-ii increases permeability of blood-tumor barrier by caveolae-mediated transcellular pathway.

Authors:  Zhen Li; Yun-hui Liu; Yi-xue Xue; Li-bo Liu; Ping Wang
Journal:  J Mol Neurosci       Date:  2013-10-25       Impact factor: 3.444

Review 3.  Towards controlled drug delivery in brain tumors with microbubble-enhanced focused ultrasound.

Authors:  Scott Schoen; M Sait Kilinc; Hohyun Lee; Yutong Guo; F Levent Degertekin; Graeme F Woodworth; Costas Arvanitis
Journal:  Adv Drug Deliv Rev       Date:  2021-11-18       Impact factor: 15.470

Review 4.  Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system.

Authors:  Muna Aryal; Costas D Arvanitis; Phillip M Alexander; Nathan McDannold
Journal:  Adv Drug Deliv Rev       Date:  2014-01-22       Impact factor: 15.470

5.  Safety Validation of Repeated Blood-Brain Barrier Disruption Using Focused Ultrasound.

Authors:  Thiele Kobus; Natalia Vykhodtseva; Magdalini Pilatou; Yongzhi Zhang; Nathan McDannold
Journal:  Ultrasound Med Biol       Date:  2015-11-23       Impact factor: 2.998

Review 6.  Physical stimuli-responsive vesicles in drug delivery: Beyond liposomes and polymersomes.

Authors:  Ulrike Kauscher; Margaret N Holme; Mattias Björnmalm; Molly M Stevens
Journal:  Adv Drug Deliv Rev       Date:  2018-10-25       Impact factor: 15.470

7.  Increasing of Blood-Brain Tumor Barrier Permeability through Transcellular and Paracellular Pathways by Microbubble-Enhanced Diagnostic Ultrasound in a C6 Glioma Model.

Authors:  Jinlong Zhang; Heng Liu; Xuesong Du; Yu Guo; Xiao Chen; Shunan Wang; Jingqin Fang; Peng Cao; Bo Zhang; Zheng Liu; Weiguo Zhang
Journal:  Front Neurosci       Date:  2017-02-23       Impact factor: 4.677

8.  Accuracy of Tumor Perfusion Assessment in Rat C6 Gliomas Model with USPIO.

Authors:  Xiang-Rong Yu; Bo-Ling Cao; Wei Li; Ye Tian; Zhong-Li Du
Journal:  Open Med (Wars)       Date:  2019-11-07

9.  In vitro stimulation of calcium overload and apoptosis by sonodynamic therapy combined with hematoporphyrin monomethyl ether in C6 glioma cells.

Authors:  Shaochun Dai; Changqing Xu; Ye Tian; Wen Cheng; Bo Li
Journal:  Oncol Lett       Date:  2014-08-05       Impact factor: 2.967

10.  Microbubble-mediated ultrasound promotes accumulation of bone marrow mesenchymal stem cell to the prostate for treating chronic bacterial prostatitis in rats.

Authors:  Shanhong Yi; Guangwei Han; Yonggang Shang; Chengcheng Liu; Dong Cui; Shuangjiang Yu; Bin Liao; Xiang Ao; Guangzhi Li; Longkun Li
Journal:  Sci Rep       Date:  2016-01-22       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.